Abstract
The chicken anaemia virus-derived protein Apoptin/VP3 (CAV-Apoptin) has the important ability to induce tumour-selective apoptosis in a variety of human cancer cells. Recently the first human Gyrovirus (HGyV) was isolated from a human skin swab. It shows significant structural and organisational resemblance to CAV and encodes a homologue of CAV-Apoptin/VP3. Using overlapping primers we constructed a synthetic human Gyrovirus Apoptin (HGyV-Apoptin) fused to green fluorescent protein in order to compare its apoptotic function in various human cancer cell lines to CAV-Apoptin. HGyV-Apoptin displayed a similar subcellular expression pattern as observed for CAV-Apoptin, marked by translocation to the nucleus of cancer cells, although it is predominantly located in the cytosol of normal human cells. Furthermore, expression of either HGyV-Apoptin or CAV-Apoptin in several cancer cell lines triggered apoptosis at comparable levels. These findings indicate a potential anti-cancer role for HGyV-Apoptin.
Original language | English |
---|---|
Article number | e296 |
Pages (from-to) | N/A |
Number of pages | 7 |
Journal | Cell Death & Disease |
Volume | 3 |
Issue number | N/A |
DOIs | |
Publication status | Published - 12 Apr 2012 |
Keywords
- apoptin
- human gyrovirus
- apoptosis
- tumour specificity
- cancer therapy
- TUMOR-CELLS
- THERAPEUTIC PROTEINS
- KINASE
- ISOFORMS